Lexington Biosciences, Inc. Stock Canadian Securities Exchange
Equities
LNB
CA5290204067
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | +6.67% | +166.67% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 36.58 50.32 |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net cash position 2021 | 664 913.41 | Net cash position 2022 * | - 0 | EV / Sales 2022 | - |
P/E ratio 2021 |
-
| P/E ratio 2022 |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 13.79% |
Managers | Title | Age | Since |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 20-04-15 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Tamara Manuel
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-4.01% | 105B | |
-4.77% | 66.74B | |
+7.87% | 52.63B | |
+16.18% | 47.48B | |
+0.26% | 39.68B | |
+7.17% | 27.78B | |
-1.23% | 26.27B | |
+3.80% | 26.11B | |
+10.60% | 25.38B |
- Stock Market
- Equities
- LXGTF Stock
- LNB Stock